Accelerate Diagnostics, Inc Insider Trading Activity
Every SEC Form 4 insider transaction reported for Accelerate Diagnostics, Inc (AXDX), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are AXDX insiders buying or selling?
Accelerate Diagnostics, Inc insiders reported 67 open-market buys ($43.7M) and 59 sells ($2.7M) across 126 Form 4 filings — a net buying position of $41.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Apr 7, 2025)
Insider sentiment
Net buyingNet insider flow of $41.0M in net buying.
Recent AXDX insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 7, 2025 | Jack Phillips | Chief Executive Officer | Sale | 25.3K | $0.65 | $16.5K |
| Apr 7, 2025 | Larry Michael Mertz | Chief Technology Officer | Sale | 1.5K | $0.65 | $989.95 |
| Apr 2, 2025 | David Patience | Chief Financial Officer | Sale | 6.8K | $0.71 | $4.8K |
| Feb 28, 2025 | David Patience | Chief Financial Officer | Sale | 535 | $1.09 | $583.15 |
| Feb 4, 2025 | Jack Phillips | Chief Executive Officer | Sale | 485 | $1.35 | $654.75 |
| Dec 4, 2024 | PATIENCE JOHN | Director | Purchase | 200.0K | $1.57 | $314.0K |
| Dec 4, 2024 | SCHULER JACK W | Director, 10% Owner | Sale | 200.0K | $1.57 | $314.0K |
| May 21, 2024 | Larry Michael Mertz | Chief Technology Officer | Sale | 361 | $0.88 | $317.68 |
| Apr 18, 2024 | Jack Phillips | Chief Executive Officer | Sale | 26.7K | $0.78 | $20.9K |
| Apr 16, 2024 | Jack Phillips | Chief Executive Officer | Sale | 26.5K | $0.86 | $22.8K |
| Apr 10, 2024 | David Patience | Chief Financial Officer | Sale | 13.3K | $0.87 | $11.6K |
| Apr 10, 2024 | Larry Michael Mertz | Chief Technology Officer | Sale | 14.0K | $0.87 | $12.2K |
| Apr 5, 2024 | Larry Michael Mertz | Chief Technology Officer | Sale | 978 | $0.88 | $860.64 |
| Apr 5, 2024 | Jack Phillips | Chief Executive Officer | Sale | 15.9K | $0.88 | $14.0K |
| Feb 27, 2024 | David Patience | Chief Financial Officer | Sale | 350 | $0.96 | $336 |
| Feb 2, 2024 | Jack Phillips | Chief Executive Officer | Sale | 494 | $1.30 | $642.2 |
| Jan 25, 2024 | Strobeck Matthew | Director | Purchase | 100.0K | $0.00 | $0 |
| Jan 25, 2024 | Louise Francesconi | Director | Purchase | 13.3K | $0.00 | $0 |
| Jan 25, 2024 | Hany Massarany | Director | Purchase | 16.7K | $0.00 | $0 |
| Jan 25, 2024 | PATIENCE JOHN | Director | Purchase | 16.7K | $0.00 | $0 |
| Dec 14, 2023 | Jack Phillips | Chief Executive Officer | Sale | 739 | $4.39 | $3.2K |
| Dec 14, 2023 | David Patience | Chief Financial Officer | Sale | 97 | $4.39 | $425.83 |
| Nov 14, 2023 | Jack Phillips | Chief Executive Officer | Sale | 745 | $5.58 | $4.2K |
| Nov 14, 2023 | David Patience | Chief Financial Officer | Sale | 97 | $5.57 | $540.29 |
| Oct 16, 2023 | David Patience | Chief Financial Officer | Sale | 96 | $5.83 | $559.68 |
Showing the 25 most recent of 126 Form 4 filings for Accelerate Diagnostics, Inc.
Most active AXDX insiders
- SCHULER JACK W50 filings
- Jack Phillips26 filings
- David Patience13 filings
- Steven Reichling13 filings
- Larry Michael Mertz8 filings
Ask anything about AXDX insider activity
Use Trabud's AI agent to query Accelerate Diagnostics, Inc's Form 4 history in plain English — "Show me AXDX CEO purchases this year" or compare it against any other ticker.
Open the AI agentAXDX insider trading FAQ
Are Accelerate Diagnostics, Inc insiders buying or selling?
Across 126 SEC Form 4 filings, Accelerate Diagnostics, Inc (AXDX) insiders reported 67 open-market purchases totaling $43.7M and 59 sales totaling $2.7M. That is a net buying position of $41.0M.
How many insiders trade AXDX stock?
12 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Accelerate Diagnostics, Inc. The most recent filing was accepted on Apr 7, 2025.
Where does Trabud get AXDX insider trading data?
All AXDX insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.